Diane Joseph-McCarthy is the Executive Director of the Bioengineering Technology & Entrepreneurship Center (BTEC) and Professor of the Practice in Biomedical Engineering at Boston University. She is a senior life science executive with over 20 years of drug discovery, development, and leadership experience in the pharmaceutical and biotechnology sector. Most recently, she was the Senior Vice President of Discovery & Early Development at EnBiotix, a bioengineering company focused on developing novel antibacterials. Before joining EnBiotix, she was an Associate Director in the Infection iMED at AstraZeneca, where she led an innovative group of scientists as well as a global team in Predictive Science. Prior to that she was at Wyeth where she held positions of increasing responsibility. She has been actively involved in the discovery of several compounds that have reached clinical trials. Dr. Joseph-McCarthy received her PhD from MIT, and was a postdoctoral fellow at Harvard University and Harvard Medical School. She has more than 75 publications/patents and has given numerous invited talks. She also has served as a member of the National Academy of Sciences Polio Antiviral Advisory Committee.